CymaBay Therapeutics, Inc. (CBAY)

1 member of Congress has disclosed 6 trades in CymaBay Therapeutics, Inc. (CBAY) via STOCK Act filings. The most recent disclosure was a purchase by Roger Marshall on 19 July 2017. Aggregate disclosed activity totals roughly $24K in purchases and $24K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for CBAY
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for CBAY

5 transactions
Compliance: 0%
Roger Marshall19 Jul 201710 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall19 Jul 201713 Aug 2020PurchaseStock$1,001 - $15,000N/A
Roger Marshall19 Jul 20176 Aug 2018PurchaseStock$1,001 - $15,000N/A
Roger Marshall19 Jul 201710 Aug 2018SaleStock$1,001 - $15,000N/A
Roger Marshall19 Jul 201713 Aug 2020SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$3.73B

Volume

8.35M

Beta

0.32

P/E Ratio

-32.81

Fundamentals

EPS

$-0.99

Div. Yield

-

Open

$32.49

Day Range

$32.48 – $32.50

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Sujal A. Shah
IPO Date
2014-02-03
Website
www.gilead.com

CymaBay Therapeutics, Inc. is a biopharmaceutical company in the clinical development phase, focused on discovering and delivering treatments for liver disorders and various other long-term illnesses. A key experimental therapy in their portfolio is...

Earnings

Recent Quarters

Q4 202328 Feb
EPS$-0.35
Miss 9.4%
Q3 20237 Nov
EPS$-0.32
Miss 6.7%
Q2 202310 Aug
EPS$-0.01
Beat 95.2%
Q1 202315 May
EPS$-0.29
Miss 81.3%
Q4 202216 Mar
EPS$-0.30
Beat 0.0%
Q3 202214 Nov
EPS$-0.28
Beat 6.7%
Q2 202211 Aug
EPS$-0.31
Miss 3.3%
Q1 202212 May
EPS$-0.32
Miss 3.2%
Q4 202117 Mar
EPS$-0.34
Beat 5.6%
Q3 202110 Nov
EPS$-0.33
Miss 13.8%
Q2 202112 Aug
EPS$-0.34
Miss 25.9%
Q1 202113 May
EPS$-0.25
Miss 4.2%
Q4 202025 Mar
EPS$-0.23
Miss 15.0%
Q3 20205 Nov
EPS$-0.17
Beat 0.0%
Q2 202010 Aug
EPS$-0.16
Beat 30.4%
Q1 202011 May
EPS$-0.19
Beat 38.7%
Q4 201912 Mar
EPS$-0.35
Beat 10.3%
Q3 20195 Nov
EPS$-0.38
Miss 2.7%
Q2 20197 Aug
EPS$-0.35
Beat 5.4%
Q1 20198 May
EPS$-0.37
Miss 8.8%
Q4 201828 Feb
EPS$-0.32
Beat 11.1%
Q3 20186 Nov
EPS$-0.34
Miss 13.3%
Q2 20189 Aug
EPS$-0.30
Miss 20.0%
Q1 20188 May
EPS$-0.32
Miss 128.6%
Q4 201715 Mar
EPS$-0.11
Beat 35.3%
Q3 20178 Nov
EPS$-0.21
Miss 10.5%
Q2 201710 Aug
EPS$-0.31
Miss 24.0%
Q1 201711 May
EPS$-0.20
Beat 25.9%
Q4 201623 Mar
EPS$-0.30
Beat 0.0%
Q3 20169 Nov
EPS$-0.25
Beat 19.4%
Q2 20169 Aug
EPS$-0.30
Beat 6.3%
Q1 201611 May
EPS$-0.29
Miss 3.6%
Q4 201529 Mar
EPS$-0.26
Beat 25.7%
Q3 201512 Nov
EPS$-0.27
Beat 22.9%
Q2 201510 Aug
EPS$-0.09
Beat 78.6%
Q1 20157 May
EPS$-0.44
Miss 2.3%
Q4 201418 Mar
EPS$-0.87
Miss 89.1%
Q3 201412 Nov
EPS$-0.44
Beat 8.3%
Q2 201414 Aug
EPS$-0.56
Beat 40.4%
Q1 201415 May
EPS$-1.02
Q3 201331 Dec
EPS$24.42
Q2 201330 Sept
EPS$58.57
Q1 201330 Jun
EPS$-0.16
Q4 201231 Mar
EPS$-0.19

6 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CBAY

Which members of Congress have traded CBAY?
1 member of Congress has disclosed 6 trade in CymaBay Therapeutics, Inc. (CBAY) under the STOCK Act: Roger Marshall.
When was CBAY most recently disclosed by Congress?
The most recent CBAY disclosure was a purchase by Roger Marshall on 19 July 2017.
What is the total disclosed congressional trading volume for CBAY?
Members of Congress have disclosed approximately $24K in CBAY purchases and $24K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CBAY?
This CBAY page updates as soon as new STOCK Act disclosures are filed for CymaBay Therapeutics, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.